Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

P > Haemostasis > Flashcards

Haemostasis Flashcards

1
Q

What two factors keep haemostasis at a state of equilibrium

A

Fibrinolytic factors and coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is coagulation

A

The simulation of blood clotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is thrombosis

A

Blood clotting - this limits the extent of the response to the area of injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is fibrinolysis

A

Breakdown of a clot as a part of healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three processes of haemostasis

A

1) contraction of blood vessels ( vasoconstriction)
2) formation of an unstable platelet drug at the site of the vessel wall damage ( primary haemostasis ) - includes platelet adhesion and
platelet aggregation
3) formation of a stable fibrin clot ( secondary coagulation )
4) dissolution of clot and vessel repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is it important to understand the haemostatic disorders?

A

Diagnose and treat bleeding disorders, identify risk factors for thrombosis, treat thrombotic disorders, monitor the drugs that are used to treat bleeding and thrombotic disorders and control bleeding in individuals who do not have any underlying bleeding disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are megakarocytes

A

A large bone marrow which is responsible for the production of platelets . Platelets are formed by the fragmentation of megakaryocyte cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do platelets do after there has been an injury to a vessel wall

A

Platelets stick to the damaged endothelium either directly to collagen via GP1a receptor or indirectly via the Von Willebrand factor which binds to the platelet GP1b receptor. This activates platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens to the shape of the platelet once it becomes activated

A

Changes from a disc to a more rounded form with spicules to encourage platelet-platelet interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is in the storage granules of platelets

A

2 types of ultrastructurally identifiable granules : alpha and dense granules. Platelet membrane forms a surface connectedcannalicukar system through which ADP, fibrinogen and Von Willebrand Factor is released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a prostaglandin

A

Prostaglandins are groups of lipids made at sites of tissue damage or infection that control processes of blood flow and blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is thromboxane A2

A

A prostaglandin that is produced from arachidonic acid that is derived from the cell membrane. Thromboxane A2 is involved in platelet aggregation and is also a vasoconstrictor that is especially imp in tissue injury and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does the granular release of ADP and generation of thromboxane A2 stimulate positive feedback ?

A

Binding to P2Y12 and thromboxane A12 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

To which receptors does fibrinogen bind

A

GPIIa/IIIa . Platelet activation causes a structural change to these receptors allowing fibrinogen to bind and then further activating and linking platelets together to form a platelet plug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What prevents inappropriate platelet aggregation

A

Active flow of blood. Prostacyclin - it is a powerful vasodilator and suppresses platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two most common anti platelet drugs

A

Aspirin and clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does aspirin work

A

Aspirin ( a selective anti inflammatory drug ) inhibits the production of thromboxane A2 by irreversible blocking the action of cyclo-oxygenase ( COX) resulting in a reduction in platelet aggregation as prostaglandin can no longer be formed . Effects of aspirin last for around 7 days , until most of the platelets have been replaced by new platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Disadvantages of high aspirin dose

A

Aspirin also interferes with the synthesis of endothelial cell prostacyclin and therefore when it is used as an anti thrombotic agent , it is used in lower doses. But endothelial cells can synthesis more COX, whereas platelets cannot as they have no nucleus to synthesis new RNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does clopidogrel work

A

Irreversibly blocks ADp receptor( P2Y12) on platelet cell membrane which stimulates platelet aggregation . Effects last for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is VWF

A

Glycoprotein that is stimulated by endothelial cells and megakaryocytes and circulates in plasma. Mediates adhesion of platelets to sited of injury and promotes platelet-platelet aggregation, also specific carrier for factor VIII.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Formation of a stable fibrin clot ( secondary haemostasis)

A

1) primary platelet plug is insufficient for small vessel injury
2) will fall apart in large vessels
3) fibrin formation stabilises platelet plug
4) thrombin cleaves fibrinogen to generate fibrin clot that stabilises platelet plug at site of injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Where are the clotting factors synthesised

A

Liver with exception of VWF and factor VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which clotting factors are made by endothelial cells

A

Factor VIII and VWF

24
Q

Vitamin K helps in the function of which clotting factors

A

Factors II( prothrombin ), VII, IX and X . Vitamin K carboxylate glutamic acid residues which is essential for the function of these clotting factors

25
Q

What is each step in blood coagulation characterised by

A

Conversion of inactive zymogen ( proenzyme) into an active clotting factor by one or more peptide bonds and exposure or active enzyme site

26
Q

Which clotting factors are cofactors

A

Factors 5 and 8

27
Q

Which metal ion plays an imp role in the binding of activated clotting factors to phospholipid surfaces of platelets

A

Calcium

28
Q

What occurs in secondary haemostasis up until the initiation phase

A

1) Blood escaping from an area of damage is exposed to tissue factor. TF is not normally exposed to blood , blood only encounters TF at sites of vascular injury
2) TF binds to factor VII in plasma and forms activates complex and coagulation is initiated
3) factor VII converts: factor X to Xa and IX to IXa

29
Q

What happens during initiation of coagulation

A

Factor Xa converts factor II ( prothrombin) to IIa( thrombin)

30
Q

What happens during amplification of coagulation

A

Thrombin activates cofactors ( V to Va and VIII to VIIIa)

31
Q

What happens during propagation of coagulation

A

Rapid burst of thrombin generation which cleaves circulation fibrinogen ( soluble) to form insoluble clot

32
Q

What are natural anticoagulant pathways

A

Inhibitory mechanisms that prevent blood from clotting completely whenever clotting is initiated by vessel injury

33
Q

Describe the inhibitory pathway between thrombin and thrombomodulin

A

Thrombin binds to thrombomodulin on the endothelial cell surface leading to the activation of protein C to activated protein C (APC). APC inactivated factors Va and VIII a ( cofactors) in the presence of co factor protein S

34
Q

Describe the anticoagulation pathway between thrombin and factor Xa

A

Thrombin and factor Xa and inactivated by circulating inhibitor antithrombin. The action of antithrombin is markedly potentiated by heparin : this occurs physiologically by binding of antithrombin to endothelial cell-associated heparins

35
Q

What are the three main anticoagulant drugs

A

Heparin, warfarin and direct oral anticoagulants (DOAFs). These drugs are used in the prevention and treatment of thrombosis

36
Q

How does heparin work

A

Indirectly by potentiatung action of antithrombin leading to the inactivation of factors Xa and IIa ( thrombin). Administered intravenously or subcutaneously ( fat layer in lower belly)

37
Q

How does Warfarin work

A

It is a vitamin K antagonist so interferes with protein carboxylation. Reduces synthesis of functional factors produced by liver ( all apart from factor VIII). Oral tablet and needs to be monitored by regular blood tests. Takes several days to take effect as reduces synthesis of coagulation factors rather than inhibiting existing coagulation factors.

38
Q

How do DOAC’s work

A

Inhibit either thrombin or factor Xa. Orally and do not unusually require monitoring

39
Q

What is the principle fibrinolytic enzyme

A

Plasmin and it circulates in it’s inactive zymogen form plasminogen. Activation of plasminogen is mediated by tissue plasminogen activator ( t-PA) . But t-PA does not activate the plasminogen until these are bothe brougth together by binding to lysine residues on fibrin. The breakdown of fibrin leads to the generation of fibrin-degredation produces.

40
Q

Is plasmin specific to fibrin

A

No, it can also break down other protein components of plasma, including fibrinogen and the clotting factors Va and VIIIa. Plasmin is inhibited by antiplasmin which circulates in blood

41
Q

What is thrombolytic therapy

A

Thrombolytic agents such as recombinant t-PA works by generating plasmin to lyse clots and are administered intravenously . High risk of bleeding associated with use. Needs to be administered quickly to people with pulmonary emboli etc.

42
Q

How do anti fibrinolytic drugs work

A

Tranexamic acid is a synthetic derivative of amino acid lysine with binds to plasminogen . Competitive inhibition so plasminogen cannot bind to lysine residues of fibrin and fibrinolysis cannot occur. Used to treat bleeding in trauma and surgical patients as well as in inherited bleeding disorders

43
Q

What is intrinsic coagulation

A

Refers to a system in which all components are in the plasma ( factors XII, XI, IX , X and cofactors VIII and V)

44
Q

What is the extrinsic system

A

Comprises of TF and factors VII, X and cofactor V

45
Q

What is a coagulation screen

A

Always includes Prothrombin time and an activated partial thromboplastin time. May include thrombin time and an assay of fibrinogen

46
Q

What is done to the plasma before coagulation screens are carried out

A

Platelet poor plasma is used and therefore the plasma from the blood is anticoagulated with sodium citrate and has been centrifuged to remove platelets

47
Q

What does the prothrombin time test

A

Assessed extrinsic pathway. A source of TF , phospholipid and calcium is added to reverse effect of citrate coagulant and time taken to clot is measured ( 12-14 sec). Dependent on factors VII, X, V and II .

48
Q

What does prothrombin time test do

A

Measures time taken for blood to clot. Measures clotting ability of factors 1,2,5,7,10. Thrombin is added to plasma for test . Results of this test are normal for people with haemophilia A ( factor 8 deficiency) and B( factor 9 deficiency).

49
Q

What is activated partial thromboplastin time

A

Assesses intrinsic pathway ( factors 12,11,9,8,10,5 and 2). Contact activator, together with phospholipid is added to citrate sample followed by calcium.

50
Q

What changes to haemostasis causes bleeding?

A

1) reduction in platelet number or function ( primary haemostasis - platelet plug)
2) reduction in coagulation factor ( secondary haemostasis - fibrin clot)
3) increased fibrinolysis

51
Q

What may cause a reduction in platelet number ( thrombocytopenia)

A

Failure of platelet production : drugs, viruses, bone marrow infiltration life megobkastic anemia, hereditary thrombocytopenia , increase in splenic pooling

52
Q

What may cause a reduction in platelet function

A

Antiplatelet drugs ( aspirin), inherited causes

53
Q

What may cause reduction in coagulation factors

A

Congenital: VWD, haemophilia A ( factor 8) , haemophilia b ( factor 9)
Aquifer: liver disease ( affects factors 2,7,9,10), anticoagulant drugs, disseminated intravascular coagulation ( DIC),

54
Q

What may cause increase in fibrinolysis

A

DIC, administration officials thrombolytic therapy ( tPA)

55
Q

What is Virchows triad( the three factors towards thrombosis)

A

Blood ( dominant in venous thrombosis ), vessel wall ( dominant in arterial thrombosis), blood flow

56
Q

Changes in blood that increases risk of venous thrombosis

A

Reduced levels of anticoagulant proteins, reduced fibrinolytic activity, increased levels of clotting factors or platelets

P (42 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions